Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.61 |
| ▸ | SQLE | Q14534 | 6/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1276617 | 1.00 | KMT2A (0.70) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL2987781 | 1.00 | KMT2A (0.70) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL28070796 | 0.97 | KMT2A (0.67) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL27497319 | 0.97 | KMT2A (0.67) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL17047981 | 0.95 | KMT2A (0.80) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL6716175 | 0.95 | KMT2A (0.80) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL3090338 | 0.95 | KMT2A (0.80) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL3090339 | 0.95 | KMT2A (0.80) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL12713311 | 0.95 | KMT2A (0.80) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL10510234 | 0.95 | KMT2A (0.80) | KMT2AMEN1CYP3A4ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250092331-A1 | COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2025-03-20 | — | — | US | claimed |
| EP-4380366-A1 | ARTHROPOD CONTROL PRODUCTS | Firmenich SA (CH) | 2024-06-12 | — | — | EP | claimed |
| CN-116218318-B | Ultrathin decorative aluminum profile and production process thereof | 浙江乔老爷铝业有限公司 | 2024-01-12 | — | — | CN | claimed |
| WO-2023144219-A1 | COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2023-08-03 | — | — | WO | claimed |
| CN-116218318-A | Ultrathin decorative aluminum profile and production process thereof | 浙江乔老爷铝业有限公司 | 2023-06-06 | — | — | CN | claimed |
| WO-2023052456-A1 | ARTHROPOD CONTROL PRODUCTS | FIRMENICH SA (CH) | 2023-04-06 | — | — | WO | claimed |
| EP-4106718-A1 | ANTIMICROBIAL COMPOSITIONS | Firmenich SA (CH) | 2022-12-28 | — | — | EP | claimed |
| CN-115066238-A | Preparation of cannabichromenes and related cannabinoids | 海湾医学公司 | 2022-09-16 | — | — | CN | claimed |
| CN-114532360-A | Antibacterial agent, preparation method thereof and antibacterial composition | 合肥杰事杰新材料股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| WO-2021094531-A1 | EMULSIONS | GIVAUDAN SA (CH) | 2021-05-20 | — | — | WO | claimed |
| US-20150065763-A1 | PETROLEUM SUBSTITUTE COMPRISED OF AN ORGANIC SOLVENT EXTRACT OF A WOODY TREE BIOMASS | PHYTOLEUM TECHNOLOGIES GROUP, L.L.C. (US) | 2015-03-05 | — | — | US | claimed |
| US-20150020441-A1 | PETROLEUM SUBSTITUTE COMPRISED OF AN ORGANIC SOLVENT EXTRACT OF HERBACEOUS PLANT BIOMASS | PHYTOLEUM TECHNOLOGIES GROUP, L.L.C. (US) | 2015-01-22 | — | — | US | claimed |
| WO-2014093748-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093828-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| EP-1307200-A2 | SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS | Wyeth (US) | 2003-05-07 | — | — | EP | claimed |
| EP-0563825-B2 | Process for producing vitamin A acid | KURARAY CO (JP) | 2002-10-02 | — | — | EP | claimed |
| WO-2002002563-A2 | SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS | WYETH (US) | 2002-01-10 | — | — | WO | claimed |
| EP-0563825-B1 | Process for producing vitamin A acid | KURARAY CO (JP) | 1995-12-27 | — | — | EP | claimed |
| US-5312978-A | Process for producing vitamin A acid | KURARAY COMPANY LTD. (JP) | 1994-05-17 | — | — | US | claimed |
| EP-0563825-A2 | Process for producing vitamin A acid | KURARAY CO., LTD. (JP) | 1993-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092331-A1 | COMPOSITIONS COMPRISING 4-ISOPROPYL-1-METHYL-7-OXABICYCLO[2.2.1]HEPTAN-2-OL OR ESTERS OR ETHERS THEREOF AND THEIR USE AS AROMA CHEMICALS | OXER1, MSMO1, IPO7 | KMT2A 2103/4885MEN1 2153/4885CYP3A4 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.